From target validation, candidate selection to preclinical and clinical studies, biomarker assays and readouts are important decision making tools. Regardless of the study type, the ability to identify and measure biomarkers with high accuracy and sensitivity is vital in making critical go/no-go decisions.
Whether you need biomarkers assay as a stand-alone service or integrated into your overall study design, Charles River provides a wide set of validated biomarker assays for a wide range of therapeutic areas, sample matrices and species, including human, to support our clients from early drug discovery to clinical studies in non-GLP and GLP environments. Both standard and customized biomarker testing are available.
Through our expertise in animal models and drug discovery and development, we can also collaborate with our clients to identify and prove utility and translatability of biomarkers. Depending on your needs, we can recommend specific translational biomarkers for your studies in certain therapeutic areas.